yttrium radioisotopes has been researched along with Neoplasm Metastasis in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (12.50) | 18.7374 |
| 1990's | 2 (4.17) | 18.2507 |
| 2000's | 17 (35.42) | 29.6817 |
| 2010's | 18 (37.50) | 24.3611 |
| 2020's | 5 (10.42) | 2.80 |
| Authors | Studies |
|---|---|
| Colaone, F; Hawkins, NS; Pollock, RF; Ross, PJ; Shergill, S; Walter, T | 1 |
| Drewes, R; Omari, J; Pech, M; Powerski, M; Relja, B; Surov, A | 1 |
| Brennan, VK; Paprottka, PM; Peters, R; Pollock, RF | 1 |
| Başaran, M; Büyükkaya, F; Engin, MN; Kovan, B; Özkan, ZG; Poyanli, A; Sağlam, S; Türkmen, C; Yilmaz, E | 1 |
| Ansquer, C; Bailly, C; Bichali Alroumani, M; Douane, F; Drui, D | 1 |
| Assifi, MM; Chung, C; Chung, MH; Doherty, MG; Shaker, TM; Varma, MK; Wolf, AM | 1 |
| Bednarz, B; Lee, D; Li, M; Schultz, MK | 1 |
| Bargellini, I; Bianchi, F; Boni, G; Bozzi, E; Cioni, R; Crocetti, L; Lorenzoni, G; Masi, G; Traino, CA | 1 |
| Carpanese, L; Cosimelli, M; Diodoro, MG; Ercolani, C; Fiore, F; Garufi, C; Giampalma, E; Golfieri, R; Izzo, F; Mancini, R; Melucci, E; Mottolese, M; Pizzi, G; Sciuto, R; Sperduti, I | 1 |
| Edeline, J; Garin, E; Laffont, S; Rolland, Y | 1 |
| Delu, A; Deming, P; Henrie, AM; Wittstrom, K | 1 |
| Akinwande, O; Hahl, M; Kelly, L; Martin, RC; McMasters, KM; Philips, P; Scoggins, CR; Tatum, C | 1 |
| Amthauer, H; Breier, L; Damm, R; Garlipp, B; Mohnike, K; Pech, M; Ricke, J; Seidensticker, M; Seidensticker, R; Steffen, IG; Ulrich, G | 1 |
| Lam, MG; Nijsen, JF; van den Bosch, MA; van der Tweel, I; van Het Schip, AD; Vente, MA; Wondergem, M; Zonnenberg, BA | 1 |
| Buscombe, JR; Cwikla, JB; Jeziorski, KG; Mikolajczak, R; Nasierowska-Guttmejer, A; Pawlak, D; Sankowski, A; Seklecka, N; Stepien, K; Walecki, J | 1 |
| Goffette, P; Jamar, F; Lhommel, R; Pauwels, S; Van den Eynde, M; van Elmbt, L; Walrand, S | 1 |
| Applebaum, L; Barak, D; Eckstein, J; Fraenkel, M; Gross, DJ; Grozinsky-Glasberg, S; Müeller-Brand, J; Shimon, I; Walter, MA | 1 |
| Baete, K; Deroose, CM; Haustermans, K; Koole, M; Mortelmans, L; Mottaghy, FM; Terwinghe, C; Van Binnebeek, S; Van Cutsem, E; Vanbilloen, B; Verbruggen, A; Verslype, C | 1 |
| Briel, M; Brunner, P; Imhof, A; Mäcke, HR; Marincek, N; Müller-Brand, J; Rasch, H; Rochlitz, C; Schindler, C; Walter, MA | 1 |
| Bilgic, S; Kucuk, ON; Lacin, S; Ozkan, E; Soydal, C | 1 |
| Bilgic, S; Kucuk, O; Lacin, S; Oz, I; Ozkan, E | 1 |
| Boy, C; Kaminsky, E; Mann, K; Metz, KA; Moeller, LC; Neumann, HP; Poeppel, TD; Rosenbaum, SJ; Yuece, A | 1 |
| Al-Nahhas, A; Ariff, B; Barwick, T; Habib, N; Hatice, G; Tait, P; Towey, D; Wasan, H; Zerizer, I | 1 |
| Bresee, C; Friedman, M; Waxman, A; Yu, R; Zalom, M | 1 |
| Jones, B; Nutting, C; Rubin, D | 1 |
| Amesur, N; Avril, N; Bienert, M; Carr, BI; Geller, DA; McCook, B; Sheetz, M; Tutor, C | 1 |
| Helmberger, T; Jacobs, TF; Münzing, W; Pöpperl, G; Schmid, R; Tatsch, K | 1 |
| Axworthy, DB; Besh, S; Breitz, H; Chen, KH; Forero-Torres, A; Khazaeli, MB; LoBuglio, AF; Meredith, RF; Percent, I; Shen, S; Sims, RB | 1 |
| Albrecht, H; Burke, PA; DeNardo, GL; DeNardo, SJ; Gregg, JP; Natarajan, A; O'Donnell, RT; Richman, CM; Yuan, A | 1 |
| Bushnell, D | 1 |
| Chu, DZ; Leong, L; Liu, A; Raubitschek, AA; Shively, JE; Wilczynski, S; Williams, LE; Wong, JY; Wu, AM; Yamauchi, DM; Yazaki, PJ; Zhan, J | 1 |
| Al-Nahhas, A; Canelo, R; Habib, N; Jiao, L; Pagou, M; Szyszko, T; Tait, P; Wasan, H | 1 |
| Du, Y; Frey, E; Prideaux, A; Sgouros, G; Song, H; Wahl, RL | 1 |
| Atassi, B; Gates, VL; Lewandowski, RJ; Nemcek, AA; Omary, R; Ryu, RK; Salem, R; Sato, KT | 1 |
| Dezarn, WA; Gulec, SA; Kennedy, AS; McNeillie, P; Mesoloras, G | 1 |
| AL-Nahhas, A; Canelo, R; Gishen, P; Stamp, G; Tait, P; Tehranipour, N; Woo, K | 1 |
| Bodei, L; Davì, MV; Falconi, M; Ferdeghini, M; Francia, G; Lo Cascio, V; Oliani, C; Paganelli, G; Testoni, M | 1 |
| Boniface, GR; DeNardo, GL; DeNardo, SJ; Goldstein, DS; Griffith, IJ; Kroger, LA; Kukis, DL; O'Donnell, RT; Richman, CM; Shen, S; Yuan, A | 1 |
| Adams, GP; Axworthy, D; Breitz, H; Bryan, K; Colcher, D; Fisher, DR; Gaffigan, S; Gentner, L; Goris, ML; Horak, ID; Knox, SJ; Tempero, M; Weiden, PL; Weiner, LM | 1 |
| DeNardo, SJ; Richman, CM | 1 |
| DeNardo, GL; DeNardo, SJ; Goldstein, DS; Griffith, IJ; Kukis, DL; Lara, PN; Martinez, GS; Meyers, FJ; Mirick, GR; O'Donnell, RT; Richman, CM; Shen, S; Yuan, A | 1 |
| Wense, G | 1 |
| Grady, ED | 1 |
| Malygina, AI; Nikitina, RG | 1 |
| Ariel, IM; Padula, G | 1 |
| Cheek, WV; Crumbley, AJ; Grady, ED; Larose, JH; Nolan, TR | 1 |
| Fand, I; Goldenberg, DM; Sharkey, RM | 1 |
| Ensminger, W | 1 |
10 review(s) available for yttrium radioisotopes and Neoplasm Metastasis
| Article | Year |
|---|---|
Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Colorectal Neoplasms; Double-Blind Method; Drug Combinations; Humans; Microspheres; Neoplasm Metastasis; Network Meta-Analysis; Palliative Care; Phenylurea Compounds; Progression-Free Survival; Pyridines; Pyrrolidines; Randomized Controlled Trials as Topic; Thymine; Trifluridine; Uracil; Yttrium Radioisotopes | 2020 |
Association between objective response rate and overall survival in metastatic neuroendocrine tumors treated with radioembolization: a systematic literature review and regression analysis.
Topics: Combined Modality Therapy; Embolization, Therapeutic; Glass; Humans; Microspheres; Neoplasm Metastasis; Neuroendocrine Tumors; Randomized Controlled Trials as Topic; Regression Analysis; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Role of Transhepatic Arterial Radioembolization in Metastatic Colorectal Cancer.
Topics: Brachytherapy; Colonic Neoplasms; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Liver Neoplasms; Neoplasm Metastasis; Rectal Neoplasms; Yttrium Radioisotopes | 2022 |
Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.
Topics: Angiography; Carcinoma, Hepatocellular; Embolization, Therapeutic; Glass; Humans; Liver; Liver Neoplasms; Lung; Maximum Tolerated Dose; Microspheres; Monte Carlo Method; Neoplasm Metastasis; Radiometry; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoembolization, Therapeutic; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Glass; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Microspheres; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Treatment Outcome; Yttrium Radioisotopes | 2009 |
Therapy with radiolabeled somatostatin peptide analogs for metastatic neuroendocrine tumors.
Topics: Clinical Trials as Topic; Humans; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Radionuclide Imaging; Somatostatin; Yttrium Radioisotopes | 2006 |
Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors.
Topics: Carcinoma, Hepatocellular; Contraindications; Embolization, Therapeutic; Humans; Liver Neoplasms; Microspheres; Neoplasm Metastasis; Radiation Injuries; Yttrium Radioisotopes | 2007 |
Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Neoplasm Metastasis; Radioimmunotherapy; Yttrium Radioisotopes | 2001 |
[Intracavitary administration of liquid radioisotopes].
Topics: Abdominal Neoplasms; Female; Gold Colloid, Radioactive; Humans; Injections, Intraperitoneal; Intestinal Neoplasms; Neoplasm Metastasis; Ovarian Neoplasms; Radiotherapy; Stomach Neoplasms; Yttrium Radioisotopes | 1978 |
Hepatic arterial chemotherapy for primary and metastatic liver cancers.
Topics: Bromodeoxyuridine; Combined Modality Therapy; Hepatic Artery; Humans; Idoxuridine; Infusions, Intra-Arterial; Liver Neoplasms; Neoplasm Metastasis; Yttrium Radioisotopes | 1989 |
8 trial(s) available for yttrium radioisotopes and Neoplasm Metastasis
| Article | Year |
|---|---|
Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheres.
Topics: Adolescent; Adult; Aged; Colorectal Neoplasms; Composite Resins; Embolization, Therapeutic; Female; Genes, bcl-2; Genes, p53; Humans; Inhibitor of Apoptosis Proteins; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Prospective Studies; Proto-Oncogene Proteins c-bcl-2; Survivin; Tumor Suppressor Protein p53; Young Adult; Yttrium Radioisotopes | 2013 |
Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Neuroendocrine; Disease Progression; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Radionuclide Imaging; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2010 |
Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radiopharmaceuticals; Yttrium Radioisotopes | 2011 |
Intra-arterial treatment with 90yttrium microspheres in treatment-refractory and unresectable liver metastases of neuroendocrine tumors and the use of 111in-octreotide scintigraphy in the evaluation of treatment response.
Topics: Adult; Aged; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiotherapy Dosage; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein.
Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Biotin; Clinical Trials as Topic; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; Gamma Cameras; Gastrointestinal Neoplasms; Glycoproteins; Humans; Indium Radioisotopes; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Radioimmunotherapy; Radioisotopes; Radiometry; Radiopharmaceuticals; Recombinant Fusion Proteins; Rhenium; Streptavidin; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2005 |
A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.
Topics: Adult; Aged; Antibodies, Monoclonal; Carcinoembryonic Antigen; Female; Heterocyclic Compounds, 1-Ring; Humans; Immunoglobulin G; Immunotoxins; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Radioimmunotherapy; Yttrium Radioisotopes | 2006 |
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.
Topics: Adult; Aged; Anemia; Antibodies, Monoclonal; Biotin; Colonic Neoplasms; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Radioimmunotherapy; Radiopharmaceuticals; Thrombocytopenia; Yttrium Radioisotopes | 2000 |
Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Animals; Antibodies, Monoclonal; Cohort Studies; Combined Modality Therapy; Humans; Indium Radioisotopes; Male; Mice; Middle Aged; Neoplasm Metastasis; Pain; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunotherapy; Radiometry; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2001 |
30 other study(ies) available for yttrium radioisotopes and Neoplasm Metastasis
| Article | Year |
|---|---|
Intra-hepatic Abscopal Effect Following Radioembolization of Hepatic Metastases.
Topics: Adult; Aged; Aged, 80 and over; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Yttrium Radioisotopes | 2020 |
Y90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?
Topics: Adult; Cohort Studies; Female; Humans; Liver Neoplasms; Male; Neoplasm Metastasis; Neuroendocrine Tumors; Progression-Free Survival; Receptors, Somatostatin; Retrospective Studies; Yttrium Radioisotopes | 2020 |
Metastatic Solitary Fibrous Tumor With Doege-Potter Syndrome: Hypoglycemia Treated by 90Y Radioembolization.
Topics: Humans; Hypoglycemia; Male; Middle Aged; Neoplasm Metastasis; Solitary Fibrous Tumors; Yttrium Radioisotopes | 2018 |
Is there a role for Ytrrium-90 in the treatment of unresectable and metastatic intrahepatic cholangiocarcinoma?
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Linear Models; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Topics: Actinium; Alpha Particles; Beta Particles; Bismuth; Dose-Response Relationship, Radiation; Humans; Lead Radioisotopes; Lutetium; Neoplasm Metastasis; Neoplasms; Radioisotopes; Yttrium Radioisotopes | 2018 |
Evaluation of Liver Biomarkers as Prognostic Factors for Outcomes to Yttrium-90 Radioembolization of Primary and Secondary Liver Malignancies.
Topics: Adult; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Disease-Free Survival; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Comparison of tumor response assessment methods in patients with metastatic colorectal cancer after locoregional therapy.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Camptothecin; Chemoembolization, Therapeutic; Colorectal Neoplasms; Doxorubicin; Embolization, Therapeutic; Female; Humans; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Proportional Hazards Models; Retrospective Studies; Yttrium Radioisotopes | 2016 |
Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system.
Topics: Adult; Aged; CA-19-9 Antigen; Carcinoembryonic Antigen; Colorectal Neoplasms; Drug Resistance, Neoplasm; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Liver; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Yttrium Radioisotopes | 2016 |
Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres.
Topics: Feasibility Studies; Female; Humans; Linear Models; Liver Neoplasms; Microspheres; Middle Aged; Neoplasm Metastasis; Phantoms, Imaging; Positron-Emission Tomography; Radiometry; Radiotherapy Dosage; Reproducibility of Results; Time Factors; Yttrium Radioisotopes | 2010 |
Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Gastrinoma; Humans; Lutetium; Male; Middle Aged; Neoplasm Metastasis; Octreotide; Radioisotopes; Receptors, Peptide; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Altered biodistribution of somatostatin analogues after first cycle of Peptide receptor radionuclide therapy.
Topics: Adult; Disease Progression; Female; Humans; Indium Radioisotopes; Intestinal Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Radioisotopes; Receptors, Peptide; Somatostatin; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors.
Topics: Carcinoma, Hepatocellular; Female; Follow-Up Studies; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Turkey; Yttrium Radioisotopes | 2011 |
Novel SDHD gene mutation (H102R) in a patient with metastatic cervical paraganglioma effectively treated by peptide receptor radionuclide therapy.
Topics: Adult; Female; Humans; Multimodal Imaging; Mutation; Neoplasm Metastasis; Octreotide; Paraganglioma; Positron-Emission Tomography; Succinate Dehydrogenase; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Yttrium Radioisotopes | 2011 |
The role of early ¹⁸F-FDG PET/CT in prediction of progression-free survival after ⁹⁰Y radioembolization: comparison with RECIST and tumour density criteria.
Topics: Adult; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Contrast Media; Disease-Free Survival; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2012 |
FDG PET/CT as a prognostic test after 90Y radioembolization in patients with metastatic hepatic disease.
Topics: Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Metastatic breast cancer in a 54-year-old woman: integrative treatment with yttrium-90 radioembolization.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Middle Aged; Neoplasm Metastasis; Yttrium Radioisotopes | 2004 |
90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors.
Topics: Adult; Aged; Angiography; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer.
Topics: Antibodies, Monoclonal; Antigens; Antigens, Neoplasm; Bone Marrow; Cathepsins; Combined Modality Therapy; Electrophoresis, Polyacrylamide Gel; Epitopes; Glycoproteins; Humans; Immunohistochemistry; Male; Maleimides; Maximum Tolerated Dose; Models, Chemical; Mucin-1; Mucins; Neoplasm Metastasis; Paclitaxel; Peptide Library; Peptides; Polyethylene Glycols; Prostatic Neoplasms; Protein Binding; Radioimmunotherapy; Radiometry; Yttrium Radioisotopes | 2005 |
Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography.
Topics: Adult; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
Therapeutic potential of 90Y- and 131I-labeled anti-CD20 monoclonal antibody in treating non-Hodgkin's lymphoma with pulmonary involvement: a Monte Carlo-based dosimetric analysis.
Topics: Adult; Antigens, CD20; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Monte Carlo Method; Neoplasm Metastasis; Phantoms, Imaging; Radioimmunotherapy; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Software; Yttrium Radioisotopes | 2007 |
Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Female; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Toll-Like Receptors; Treatment Outcome; Yttrium; Yttrium Radioisotopes | 2007 |
Concordant F-18 FDG PET and Y-90 Bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: confirmation with histopathology.
Topics: Drug Delivery Systems; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal.
Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Cushing Syndrome; Female; Gastrinoma; Humans; Neoplasm Metastasis; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Yttrium Radioisotopes | 2008 |
Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A.
Topics: Adult; Animals; Antibodies, Monoclonal; Breast Neoplasms; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mice; Middle Aged; Neoplasm Metastasis; Radioimmunotherapy; Radiotherapy Dosage; Transplantation, Autologous; Yttrium Radioisotopes | 1999 |
[The efficacy of radiohypophysectomy with yttrium 90 in metastatic breast cancer (author's transl)].
Topics: Austria; Breast Neoplasms; Female; Hospitals, University; Humans; Neoplasm Metastasis; Palliative Care; Pituitary Irradiation; Yttrium Radioisotopes | 1979 |
Intrahepatic arterial 90-yttrium resin spheres to treat liver cancer.
Topics: Adult; Carcinoma, Hepatocellular; Female; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Neoplasm Metastasis; Radiotherapy Dosage; Resins, Plant; Yttrium Radioisotopes | 1978 |
Treatment of symptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes.
Topics: Catheters, Indwelling; Colonic Neoplasms; Femoral Artery; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Neoplasm Metastasis; Prognosis; Rectal Neoplasms; Yttrium Radioisotopes | 1978 |
Internal hepatic radiotherapy: I. Organ distribution of colloidal Cr32 PO4 injected into a peripheral vein, the portal vein, or the arterial supply of the gastrointestinal tract in the rat.
Topics: Animals; Autoradiography; Chromium Radioisotopes; Colloids; Digestive System; Female; Injections, Intra-Arterial; Injections, Intravenous; Liver; Liver Neoplasms; Microspheres; Neoplasm Metastasis; Neoplasms, Experimental; Portal Vein; Rats; Yttrium Radioisotopes | 1975 |
Use of whole-body autoradiography in cancer targeting with radiolabeled antibodies.
Topics: Animals; Antibodies, Monoclonal; Autoradiography; Boron; Carcinoembryonic Antigen; Cricetinae; Immunoglobulin Fab Fragments; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Radionuclide Imaging; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes | 1990 |